Literature DB >> 9032276

Incubation at the nonpermissive temperature induces deficiencies in UV resistance and mutagenesis in mouse mutant cells expressing a temperature-sensitive ubiquitin-activating enzyme (E1).

H Ikehata1, S Kaneda, F Yamao, T Seno, T Ono, F Hanaoka.   

Abstract

In temperature-sensitive (ts) mutants of mouse FM3A cells, the levels of mutagenesis and survival of cells treated with DNA-damaging agents have been difficult to assess because they are killed after their mutant phenotypes are expressed at the nonpermissive temperature. To avoid this difficulty, we incubated the ts mutant cells at the restrictive temperature, 39 degrees C, for only a limited period after inducing DNA damage. We used ts mutants defective in genes for ubiquitin-activating enzyme (E1), DNA polymerase alpha, and p34(cdc2) kinase. Whereas the latter two showed no effect, E1 mutants were sensitized remarkably to UV light if incubated at 39 degrees C for limited periods after UV exposure. Eighty-five percent of the sensitization occurred within the first 12 h of incubation at 39 degrees C, and more than 36 h at 39 degrees C did not produce any further sensitization. Moreover, while the 39 degrees C incubation gave E1 mutants a moderate spontaneous mutator phenotype, the same treatment significantly diminished the level of UV-induced 6-thioguanine resistance mutagenesis and extended the time necessary for expression of the mutation phenotype. These characteristics of E1 mutants are reminiscent of the defective DNA repair phenotypes of Saccharomyces cerevisiae rad6 mutants, which have defects in a ubiquitin-conjugating enzyme (E2), to which E1 is known to transfer ubiquitin. These results demonstrate the involvement of E1 in eukaryotic DNA repair and mutagenesis and provide the first direct evidence that the ubiquitin-conjugation system contributes to DNA repair in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032276      PMCID: PMC231874          DOI: 10.1128/MCB.17.3.1484

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Effects of aphidicolin and/or 2',3'-dideoxythymidine on DNA repair induced in HeLa cells by four types of DNA-damaging agents.

Authors:  K Yamada; F Hanaoka; M Yamada
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

2.  Isolation and analysis of a mammalian temperature-sensitive mutant defective in G2 functions.

Authors:  C Mineo; Y Murakami; Y Ishimi; F Hanaoka; M Yamada
Journal:  Exp Cell Res       Date:  1986-11       Impact factor: 3.905

3.  Specificity and frequency of ultraviolet-induced reversion of an iso-1-cytochrome c ochre mutant in radiation-sensitive strains of yeast.

Authors:  C W Lawrence; J W Stewart; F Sherman; R Christensen
Journal:  J Mol Biol       Date:  1974-05-05       Impact factor: 5.469

4.  Characterization of a temperature-sensitive mutant of mouse FM3A cells defective in DNA replication.

Authors:  Y Murakami; H Yasuda; H Miyazawa; F Hanaoka; M Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85.

Authors:  A Ciechanover; D Finley; A Varshavsky
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

6.  Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85.

Authors:  D Finley; A Ciechanover; A Varshavsky
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

7.  DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall.

Authors:  V A Bohr; C A Smith; D S Okumoto; P C Hanawalt
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

8.  Establishment of cell lines in vitro from a mammary ascites tumor of mouse and biological properties of the established lines in a serum containing medium.

Authors:  N Nakano
Journal:  Tohoku J Exp Med       Date:  1966-01-25       Impact factor: 1.848

9.  Purification of PCNA as a nucleotide excision repair protein.

Authors:  A F Nichols; A Sancar
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

10.  Characterization of postreplication repair in Saccharomyces cerevisiae and effects of rad6, rad18, rev3 and rad52 mutations.

Authors:  L Prakash
Journal:  Mol Gen Genet       Date:  1981
View more
  6 in total

1.  Aberrant DNA polymerase alpha is excluded from the nucleus by defective import and degradation in the nucleus.

Authors:  Christian S Eichinger; Takeshi Mizuno; Keiko Mizuno; Yasuyuki Miyake; Ken-ichiro Yanagi; Naoko Imamoto; Fumio Hanaoka
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

2.  Impaired nucleotide excision repair upon macrophage differentiation is corrected by E1 ubiquitin-activating enzyme.

Authors:  Thierry Nouspikel; Philip C Hanawalt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

3.  Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome.

Authors:  Ivana De Domenico; Michael B Vaughn; Liangtao Li; Dustin Bagley; Giovanni Musci; Diane M Ward; Jerry Kaplan
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

4.  The molecular mechanism of hepcidin-mediated ferroportin down-regulation.

Authors:  Ivana De Domenico; Diane McVey Ward; Charles Langelier; Michael B Vaughn; Elizabeta Nemeth; Wesley I Sundquist; Tomas Ganz; Giovanni Musci; Jerry Kaplan
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

5.  DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation.

Authors:  Qi-En Wang; Qianzheng Zhu; Gulzar Wani; Mohamed A El-Mahdy; Jinyou Li; Altaf A Wani
Journal:  Nucleic Acids Res       Date:  2005-07-19       Impact factor: 16.971

Review 6.  The ubiquitin-proteasome pathway in cancer.

Authors:  V Spataro; C Norbury; A L Harris
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.